IN PARTNERSHIP


high-density populations of minority groups encourages more to sign up and attend trials. Remote options support people who live in rural areas and expand your potential participants.


8. Include Detailed Questions To ensure diverse participation, include thorough questionnaires and paperwork to understand your patients fully. For instance, until recently, many patients


coldnt fill in boes for their seal orientation or gender identification. This may have led to underrepresented demographics. Another common example is providing an Asian American race option bt not acconting for heritage, such as Chinese, Japanese, or ietnamese. The genetic variations significantly impact a patients ssceptibility to disease. Be sure to include socio-economic questions becase of their significant impact on trial outcomes.


9. Invest in Translations and Interpretation According to the United States Census Bureau, over one in five people in the .. spea a language other than English.3 Translators and multilingual marketing


materials support diverse participants. For eample, fier offers mltilingal resorces.


10. Ask for Feedback ontinally listen to participants before, dring, and after the trial through surveys and feedbac reests. By checking in throughout and through a


survey, you can monitor participant satisfaction and identify any issues with inclusion and equity. rther resorces are available on the Clinical Trial Diversity FDA page.5


Are You Ready to Support DEI in Your Trials? I is becoming more crcial as researchers realie the impact of demographic and socio-economic factors on participants. Use these ten tips in your future trials to ensure consistent and accurate results that apply to the most at-risk demographics.


References 1. Versavel, S., Subasinghe, A., John- son, K., Golonski, N., Muhlhausen, J., Perry, P., & Sanchez, R. (2023, January 23). Diversity, equity, and inclusion in clinical trials: A practical guide from the perspective of a trial sponsor. ScienceDirect. https://www.sciencedirect. com/science/article/pii/ S1551714423000150#:~:text=Back- grond,tobenefitfrom those%20therapies


2. U.S. Department of Health & Human Services (2023, April 24). Diversity and Inclusion in Clinical Trials. Nation- al Institute of Health. https://www.nimhd.nih.gov/resources/ understanding-health-disparities/di- versity-and-inclusion-in-clinical-trials. html


3. Dietrich, Sandy, Hernandez, Erik , ecember . early  il- lion People Spoke a Language Other Than English at Home in 2019. United States Census Bureau. httpswww.censs.govlibrarypbli- cations/2022/acs/acs-50.html


4. Diversity Plans to Improve Enroll- ment of Participants from Underrep- resented Racial and Ethnic Popula- tions in Clinical Trials Guidance for Industry (fda.gov) (April 2022)


5. Clinical Trial Diversity | FDA


6. H.R.2617-Consolidated Appropri- ations Act, 2023. , ecember . ongress.ov. ..  th Congress (2021-2022): Consolidat- ed Appropriations Act, 2023. (2022, ecember . https://www.congress.gov/ billthcongresshosebill


58 | Outsourcing In Clinical Trials


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72